Latest News
Breckenridge Pharmaceutical launches Pomalidomide Capsules in US market
3 March 2026 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International, announced on Monday the launch of Pomalidomide Capsules, a generic version of Pomalyst by Celgene (now Bristol Myers Squibb), within the oncology the...
Ono Pharmaceutical expands multi-target research collaboration with Congruence Therapeutics
3 March 2026 - Japan-based Ono Pharmaceutical Co Ltd announced on Monday an expansion of its multi-target research collaboration with Canadian biotechnology company Congruence Therapeutics.The expanded collaboration is focused on two clinically valid...
BD receives FDA clearance for Surgiphor 1000mL irrigation system
...
United Therapeutics' ralinepag reduces risk of clinical worsening in pivotal PAH study
2 March 2026 - Biotechnology company United Therapeutics Corporation (Nasdaq:UTHR) announced on Monday that its long-term pivotal phase 3 ADVANCE OUTCOMES study of ralinepag met the primary endpoint, showing a 55% reduction in the risk of clinical wo...
Genentech's fenebrutinib meets primary endpoint in pivotal Phase III study for multiple sclerosis
2 March 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Monday that its Phase III FENhance 1 study in relapsing multiple sclerosis (RMS) met the primary endpoint, showing that fenebrutin...